Usmani, Sahabi .
HRN: 21-22-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
06/18/2024
06/20/2024
ORAL
5ml
Bid
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes